HAO Market Analysis
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- 0.00
- P/B
- 0.07
- P/S (TTM)
- 0.01
- EV/EBITDA
- 13.53
Profitability & growth
- ROE (TTM)
- -16.0%
- Operating margin
- -16.8%
- Revenue growth YoY
- 41.2%
- Dividend yield
- —
- Beta
- -1.46
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Haoxi Health Technology Limited Class A Ordinary Shares
Company profileHaoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, focused on revolutionizing healthcare through innovative, technology-driven solutions. The company harnesses advanced artificial intelligence and data analytics to enhance diagnostic precision, streamline treatment processes, and improve patient management. With a robust commitment to research and development, Haoxi is well-positioned to tackle emerging healthcare challenges, presenting substantial growth opportunities for institutional investors aiming to leverage advancements in…
Classification
- Sector
- Communication Services
- Industry
- Advertising Agencies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- TOWER C, BUILDING 103, CHAOYANG
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
